Form 4: Apyx Medical Corp Director Wendy Levine Acquires 17,000 Stock Options

Director Wendy Levine acquired 17,000 stock options in Apyx Medical Corp on August 8, 2024, as part of the Director Compensation Program.

Summary

• Wendy Levine, a director of Apyx Medical Corp, acquired 17,000 stock options on August 8, 2024.
• The options have an exercise price of $1.02.
• The options were issued as part of the Issuer's Director Compensation Program.
• The options vest ratably over a 12-month period and become fully vested and exercisable on the first anniversary of the grant date.
• Following the transaction, Ms. Levine directly owns 17,000 derivative securities.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure of a director's stock option grant, which is a standard part of compensation.

Industry Context

This is a standard Form 4 filing, reflecting a director's acquisition of stock options, which is a common component of director compensation packages in publicly traded companies.

Stakeholder Impact

• The acquisition of stock options by a director aligns their interests with those of the shareholders, as the value of the options is tied to the company's stock performance.

Key Dates